MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Archives & Legacy
*Organization & Developments: ACADIA Pharmaceuticals (Archives 2016-2018)
Parents
Archives & Legacy
Organization & Developments: ACADIA Pharmaceuticals
Children
2016: Acadia Pharmaceuticals: Another Look At Alzheimer's Disease Psychosis Trial Design - ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
2016: Biotech Forum Daily Digest: Acadia, Collaboration Deals Boost Akebia And Conatus. Spotlight On Anika Therapeutics - iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)
2016: Review Of Acadia's Weak Pimavanserin Phase II Results For Alzheimer's Disease Psychosis - ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
2016: Where Acadia Will Go After FDA Approval - ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
2017: ACADIA: A Buyout Remains Most Likely Scenario - ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
2017: Closing Danger Zone Pick: Acadia Healthcare - Acadia Healthcare Co. (NASDAQ:ACHC)
2017: VA_65--Acadia Pharmaceuticals Inc. Contract Award Effective 1/15/2017
2018: Acadia Pharmaceuticals Is A Promising Buy In 2018_seekingalpha.com
2018: Acadia Pharmaceuticals Plunges Following Report that Links Nuplazid to High Number of Deaths
2018: ACADIA Pharmaceuticals: Due For A Rebound - ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
2018: Acadia Receives A Rubber Stamp From FDA On Nuplazid Risk-Benefit Profile_seekingalpha.com
2018: What Now For Acadia Pharmaceuticals?_seekingalpha.com
2018: Why Acadia Pharmaceuticals Stock Is Crashing Today